We then suppressed expression of FAT1 or MIB2 using lentiviral transfer of shRNA directed against FAT1 or MIB2 in Hela cells and in the FAT1-expressing HNSCC CAL27 (S7A and B Fig) and analyzed the growth of tumor cells in vivo after subcutaneous injection. The gene discussed is MIB2; the disease is neoplasm.